Sygnis Overview

  • Founded
  • 2008
  • Status
  • Public
  • Employees
  • 11
  • Stock Symbol
  • LIOK
Stock Symbol
  • Investments
  • 2

Sygnis General Information


Developer of products designed to replicate DNA. The company is involved in the identification of new polymerases and development and exploitation of polymerase applications for the sequencing, repair and amplification of DNA and the development of biomarkers for diagnostic and therapeutic uses.

Contact Information

Formerly Known As
X-Pol Biotech
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Commercial Services
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
Primary Office
  • Waldhofer Street 104
  • 69123 Heidelberg
  • Germany
+49 03491 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sygnis Financials Summary

In Thousands,
TTM 31-Dec-2019 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
Revenue 1,340 1,340 16,940 8,901
EBITDA (4,240) (4,240)
Total Assets 69,732 69,732 73,412 59,952
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sygnis Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sygnis‘s full profile, request access.

Request a free trial

Sygnis Executive Team (7)

Name Title Board Seat Contact Info
Heikki Lanckriet Ph.D Chief Executive Officer & Chief Scientific Officer
David Roth Chief Financial Officer
Nick Gee Chief Technology Officer
Luis Blanco Dávila Co-Founder & Advisor
Margarita Salas Co-Founder & Advisor
You’re viewing 5 of 7 executive team members. Get the full list »

Sygnis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sygnis Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Mar-2018 000000000000000000 000.00 Biotechnology 00000 00 00 000000
C.B.S. Scientific Company 01-Jan-2017 Merger/Acquisition 00000 Other Devices and Supplies 00000 00 00 000000
To view Sygnis’s complete acquisitions history, request access »

Sygnis Subsidiaries (2)

Company Name Industry Location Founded
4basebio Biotechnology Heidelberg, Germany 1997
0.0.0. 0000000000 Other Devices and Supplies San Diego, CA 0000
To view Sygnis’s complete subsidiaries history, request access »